Olysio Fact Sheet
Olysio (simeprevir) is an HCV-fighting drug. It must be used with other drugs to treat hepatitis C. In the United States, Olysio is approved for people with hepatitis C genotype 1 who are over 18 years old.
Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions
This brief review provides community recommendations for research that requires HIV-positive people to interrupt antiretroviral treatment (ART).
Story: Stem Cell Transplants for Cancers “Cleared” HIV in Two Australians
July 2014 Examples of media coverage: HIV “Cleared” in Two Australian Men after Bone-Marrow Transplants– Sydney Morning Herald, July 19, 2014 HIV Said Cleared in Two Bone Marrow Transplant Patients– Bloomberg News, July 18, 2014 Cancer Treatment Clears Two Australian Patients…
TAG, CRAG, and TB CAB Letter Calling for Compassionate Use Program for Delamanid
TAG, CRAG, and the TB CAB issues urgent appeal for Otsuka to initiate its long overdue compassionate use program by the end of 2013.
Have a Heart, Save My liver!
February 14, 2013 – Today, on the occasion of Valentine's Day, Médecins du Monde and Treatment Action Group (TAG) are launching an action urging pharmaceutical giants Merck and Roche to drop their exorbitant prices for pegylated interferon, an effective hepatitis…